Immune microenvironment in clear cell type renal cell carcinoma with loss of PBRM1 protein expression

被引：0
|
作者：
Miura, Yuji [1 ]
Motoshima, Takanobu [2 ]
Inoshita, Naoko [3 ]
Okaneya, Toshikazu [4 ]
Takano, Toshimi [1 ]
Komohara, Yoshihiro [5 ]
机构：
[1] Toranomon Gen Hosp, Dept Med Oncol, Minato City, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Urol, Kumamoto, Japan
[3] Toranomon Gen Hosp, Dept Pathol, Minato City, Japan
[4] Toranomon Gen Hosp, Dept Urol, Minato City, Japan
[5] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz338.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO1 - 9 -
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma
    Bihr, Svenja
    Ohashi, Riuko
    Moore, Ariane L.
    Ruschoff, Jan H.
    Beisel, Christian
    Hermanns, Thomas
    Mischo, Axel
    Corro, Claudia
    Beyer, Jorg
    Beerenwinkel, Niko
    Moch, Holger
    Schraml, Peter
    NEOPLASIA, 2019, 21 (02): : 247 - 256
  • [42] PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma
    Joseph Walton
    Keith Lawson
    Panagiotis Prinos
    Antonio Finelli
    Cheryl Arrowsmith
    Laurie Ailles
    Nature Reviews Urology, 2023, 20 : 96 - 115
  • [43] Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma
    Braun, David A.
    Ishii, Yuko
    Walsh, Alice M.
    Van Allen, Eliezer M.
    Wu, Catherine J.
    Shukla, Sachet A.
    Choueiri, Toni K.
    JAMA ONCOLOGY, 2019, 5 (11) : 1631 - 1633
  • [44] PBRM1 loss defines distinct tumor phenotype associated with immunotherapy resistance in renal cell carcinoma
    Liu, Xiande
    Kong, Wen
    Peterson, Christine
    McGrail, Daniel
    Anh Hoang
    Zhang, Xuesong
    Truong Lam
    Pilie, Patrick
    Zhu, Haifeng
    Beckermann, Kathryn
    Haake, Scott
    Isgandrova, Sevinj
    Martinez-Moczygemba, Margarita
    Sahni, Nidhi
    Rathmell, W. Kimryn
    Jonasch, Eric
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [45] Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma
    Xu, Ziyang
    Jiang, Wenbin
    Liu, Li
    Qiu, Youqi
    Wang, Jiahao
    Dai, Siyuan
    Guo, Jianming
    Xu, Jiejie
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (05)
  • [46] Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma
    A Murakami
    L Wang
    S Kalhorn
    P Schraml
    W K Rathmell
    A C Tan
    R Nemenoff
    K Stenmark
    B-H Jiang
    M E Reyland
    L Heasley
    C-J Hu
    Oncogenesis, 2017, 6 : e287 - e287
  • [47] An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC)
    Wang, Yuanyuan
    Guo, Xingyi
    Bray, Michael J.
    Ding, Zhiyong
    Zhao, Zhongming
    BMC GENOMICS, 2016, 17
  • [48] Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway
    Gad, Sophie
    Le Teuff, Gwenael
    Nguyen, Baptiste
    Verkarre, Virginie
    Duchatelle, Veronique
    Molinie, Vincent
    Posseme, Katia
    Grandon, Benjamin
    Da Costa, Melanie
    Job, Bastien
    Meurice, Guillaume
    Droin, Nathalie
    Mejean, Arnaud
    Couve, Sophie
    Renaud, Flore
    Gardie, Betty
    Teh, Bin Tean
    Richard, Stephane
    Ferlicot, Sophie
    ONCOLOGY LETTERS, 2021, 22 (06)
  • [49] FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
    Zhong, Guanghui
    Li, Qing
    Luo, Yang
    Liu, Yufeng
    Liu, Dawei
    li, Bin
    Wang, Tao
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [50] An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC)
    Yuanyuan Wang
    Xingyi Guo
    Michael J. Bray
    Zhiyong Ding
    Zhongming Zhao
    BMC Genomics, 17
12345